FTCM
CERE

First Trust Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

First Trust Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250,985
Closed -$10.3M – 141
2024
Q2 		$10.3M Sell
250,985
-25,244
-9% -$1.05M 0.94% 31
2024
Q1 		$11.7M Buy
+276,229
New +$11.6M 0.99% 25

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

First Trust Capital Management's CERE Position: Q3 2024 in Review

First Trust Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 250,985 shares — an estimated $10.3M sold.

First Trust Capital Management first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $11.7M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • First Trust Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • First Trust Capital Management sold 250,985 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $10.3M.
  • First Trust Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • First Trust Capital Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $11.7M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on First Trust Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.